Clinical Trial Research
Reports from Mansoura University describe recent advances in clinical trial research
Published in Blood Weekly, June 11th, 2009
According to recent research from Mansoura, Egypt, "The aim of the study was to assess whether the C-2 level is a good parameter to predict a drug's maximal concentration C-MAX values in Egyptian kidney transplant recipients (KTR). Fifty stable kidney transplant recipients (KTR) with a previously confirmed diagnosis of schistosomal infection compared to KTR (n = 50) without schistosomal infection regarding CsA concentrations at time 0 (trough), 1.5, 2, 2.5, 3, and 3.5 h post-CsA."
"Statistical significance of linear regression between different CsA time concentrations and drug dosages was calculated. Patients in schistosomal group, had significantly lower C-2 levels...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2009-06-11)
More Articles from Blood Weekly
- Massachusetts General Hospital
Automated analysis of MR images may identify early Alzheimer’s disease - Acute Myeloid Leukemia
Investigators at University of Munich release new data on acute myeloid leukemia - Angiotensins
Research on angiotensins described by L.H. Shen and colleagues - Bacteremia
Research in the area of bacteremia reported from G.R. Corey and colleagues - Blood Safety
Reports from University of Washington advance knowledge in blood safety - Candidiasis
Investigators at University of Seville target candidiasis - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
